Making HIV, tuberculosis and hepatitis C treatment affordable
Many developing countries around the world do not have access to affordable, lifesaving medicines. To achieve Sustainable Development Goal 3: “Ensure healthy lives and promote well-being for all, at all ages”, essential medicines must be affordable. Public health initiatives that increase competition, such as voluntary licensing, have brought about significant price reductions for medicines to treat HIV, TB and hepatitis C, but in some cases voluntary licenses may not be available to all developing countries.
ITPC will work with local civil society organizations and patient groups in different developing countries to overcome barriers to HIV, TB and hepatitis C medicines. ITPC will capacitate and encourage local stakeholders to use tools provided by national laws and international agreements to assure the quality of the patents that are granted and to increase the supply of generic medicines that will lead to a price reduction of lifesaving medicines. In addition, ITPC will prepare the market for entry and uptake of optimized generic products.
The impact we are seeking
The project aims to promote access to more affordable treatments in developing countries that lack access, allowing governments to put more people on treatment.